Study identifies new disease-inducing mechanism for inflammatory bowel disease
Combined, Crohn’s disease and ulcerative colitis affect over 500,000 people in the UK
Read More
Tag: Ulcerative Colitis
Francis Crick researchers reveal pathways linking intestinal inflammation and colitis
Affecting over 500,000 people in the UK, IBD comprises Crohn’s disease and ulcerative colitis
Read More
TVM and Tillotts form company to take on ulcerative colitis
Mage Biologics aims to progress a novel, orally administered monoclonal antibody
Read More
Takeda takes the lead on Finch’s ulcerative colitis candidate FIN-524
The clinical development programme is now known as TAK-524
Read More
Seres’ ulcerative colitis candidate misses primary endpoint in mid-stage study
Microbiome-based therapeutic failed to improve clinical remission rates among mild-to-moderate ulcerative colitis patients
Read More
Galapagos’ filgotinib leads to rapid symptom improvement for ulcerative colitis patients
Data also suggested filgotinib 200mg reduced and eliminated corticosteroid use compared to placebo
Read More
Rinvoq scores positive results as a maintenance therapy for ulcerative colitis
JAK inhibitor hit primary endpoint of improved clinical remission at 52 weeks in maintenance study
Read More
Abivax’s ABX464 shows ‘impressive’ efficacy in severe ulcerative colitis patients
Once-daily oral treatment was well-tolerated and demonstrated a good safety profile in Phase IIb study
Read More
Lilly’s mirikizumab hits primary endpoint in ulcerative colitis study
Patients treated with monoclonal antibody achieved clinical remission at week 12
Read More
EMA begins evaluation of filgotinib for ulcerative colitis
Gilead and Galapagos’ application for oral JAK1 inhibitor validated by agency
Read More
BMS’ Zeposia hits the mark in ulcerative colitis
Oral S1P receptor modulator hit both primary endpoints in a phase III trial
Read More
Roche post mixed results for etrolizumab in ulcerative colitis
Phase III study of drug in Crohn’s disease is ongoing
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
